Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis.
about
Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal developmentCurrent perspectives on the immunopathogenesis of systemic sclerosisSystemic Sclerosis and the Gastrointestinal Tract-Clinical ApproachCalciphylaxis and metastatic calcification associated with nephrogenic fibrosing dermopathy.Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer.Tissue elasticity and the ageing elastic fibre.Reversal of tumor immune inhibition using a chimeric cytokine receptor.A portable dermatoscope for easy, rapid examination of periungual nailfold capillary changes in patients with systemic sclerosis.Serum neurotrophin profile in systemic sclerosisGlobal chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.A soluble factor from Trypanosoma cruzi inhibits transforming growth factor-ß-induced MAP kinase activation and gene expression in dermal fibroblasts.Lysophosphatidic Acid Upregulates Laminin-332 Expression during A431 Cell Colony Dispersal.Serum endoglin levels in patients suffering from systemic sclerosis and elevated systolic pulmonary arterial pressureTransforming growth factor-beta and fibrosisEpidemiology and pathogenesis of scleroderma.Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors.Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activityRegulation of fibronectin-EDA through CTGF domain-specific interactions with TGFβ2 and its receptor TGFβRIIMicrovascular abnormalities in patients with early systemic sclerosis: less severe morphological changes than in patients with definite disease.Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis.The role of macrophage migration inhibitory factor in mast cell-stimulated fibroblast proliferation and collagen production.Smad3 as a mediator of the fibrotic response.Transforming growth factor-β increases interleukin-13 synthesis via GATA-3 transcription factor in T-lymphocytes from patients with systemic sclerosis.Post-occlusive reactive hyperaemia (POHR) in systemic sclerosis: very early disease (VEDOSS) represents a separate entity compared to established disease.Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts.Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance.Fibrogenesis in Crohn's disease.Update on pathophysiology of scleroderma with special reference to immunoinflammatory events.Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.Effects of glucagon-like peptide-1 receptor agonists on renal functionWhat epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases.Regulatory mechanisms of TGF-β1-induced fibrogenesis of human alveolar epithelial cells.The immunology of fibrosis: innate and adaptive responses.Activated alveolar epithelial cells initiate fibrosis through autocrine and paracrine secretion of connective tissue growth factor.Evidence of an antifibrotic effect of immunosuppressive drugs: applications in the treatment of systemic sclerosis.Exploring anti-TGF-β therapies in cancer and fibrosis.Fibroblast abnormalities in the pathogenesis of systemic sclerosis.Irradiation-induced morphea: x-rays as triggers of autoimmunity.Cell-type-specific differentiation and molecular profiles in skin transplantation: implication of medical approach for genetic skin diseases.
P2860
Q24616861-D79BA413-A808-4B9D-8979-22DBFE7FFF67Q26741264-C95EE6C8-D9D4-4D1A-8EFA-AFC57BE0EA11Q28079598-3579E49D-C063-4DEC-BEF0-2D9B2907C08CQ30312127-9A55EAC6-90F2-4746-9FC0-5AF851C70A9CQ30438371-6B28DBA2-617E-4439-96BC-CF973DAA6587Q30476541-C384CF9C-40D0-4148-BEA9-F805246485DFQ30478322-00A3F169-5352-46BD-8EC7-A6A4AB0A7DB9Q30580134-8DD00C95-FCA8-40FA-85DF-69DC987DF794Q33588697-07FAE186-D1E1-4043-B3A2-DDC2ECF31388Q33749854-86C2C5E2-7A6D-41C7-8045-4039DFDE65EFQ33826259-5423B190-CABC-48C8-B730-BB908B560660Q34023102-68F19793-0D6F-479D-9885-080EA067D07BQ34123656-5452C77C-10DD-4688-8DBA-D675D4078C7BQ34143652-F42A52CF-06E0-4312-9FB1-5B5079E3F8BAQ34232534-3B4FBF07-EAB6-4B3D-9CF6-656AF7C1A832Q35064351-4126AD35-797A-4ECA-A9AD-F7DED825A8F7Q35070899-BC0978A7-32E2-4EAB-9C5D-C73F6E8EFFDCQ35085132-B9BFD0A8-F6BA-4962-8592-32DB42AE6ED4Q35221297-BCDEC3A5-3CE7-4506-B10D-C1BEDE972637Q35403273-434761ED-918F-4DAB-8BF0-445BB84AF7DFQ35554610-2F35FF03-FA27-4346-B621-E7C7D5380074Q35591011-1ADA1669-DF21-4270-8EA5-3DFD034D5F36Q35779047-A2B3FAE1-EF4A-43CC-BBC0-3C269C62ACF3Q35906260-CA14AA4F-38F9-4EEE-AC0D-66FAD2C4CE96Q35947179-91E4BFA8-206A-4592-9565-0589D2D5C00EQ36051223-E07151F1-46D9-4470-A62E-5653D250A4E6Q36076333-5DAA42E3-F9BA-435A-8783-DE3B91F6F2E4Q36677634-3F66DE66-2D8E-4409-B0E0-D70F67635A29Q36761364-14D1E6A3-F44F-4E56-BBD5-5FE33EC8AE65Q37224668-B514B690-04AD-4102-9C16-2085FC9A9971Q37232679-7E3182EB-6A6F-4C6D-8C08-0986F0CCDAD0Q37270709-60575DBF-6ED5-45FE-9C21-2926EC4A600CQ37370819-B05124AF-DD87-42C1-BC13-04A3E6025443Q37682484-04D25B79-94CF-4EB7-A987-DA1A7FD93536Q37707606-A3087246-CEE3-43F6-B9BB-FB55E6D36686Q37754503-E6B875BF-AE7A-4680-93EF-4B95EC05989DQ37896073-C03F9A9D-DB38-480F-BA82-1F74E9B5F714Q37905795-8C9C8499-8334-4317-B90A-26100C3A7FB6Q37921996-26940FA9-0D42-4F7F-A585-320DBB28FF1BQ37969117-792CB59C-C2C7-41E4-9D4A-F41C2E5CDF01
P2860
Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Transforming growth factor-bet ...... s in scleroderma pathogenesis.
@ast
Transforming growth factor-bet ...... s in scleroderma pathogenesis.
@en
Transforming growth factor-bet ...... s in scleroderma pathogenesis.
@nl
type
label
Transforming growth factor-bet ...... s in scleroderma pathogenesis.
@ast
Transforming growth factor-bet ...... s in scleroderma pathogenesis.
@en
Transforming growth factor-bet ...... s in scleroderma pathogenesis.
@nl
prefLabel
Transforming growth factor-bet ...... s in scleroderma pathogenesis.
@ast
Transforming growth factor-bet ...... s in scleroderma pathogenesis.
@en
Transforming growth factor-bet ...... s in scleroderma pathogenesis.
@nl
P1476
Transforming growth factor-bet ...... s in scleroderma pathogenesis.
@en
P2093
P304
P356
10.1097/00002281-200111000-00010
P577
2001-11-01T00:00:00Z